|
SF3B3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.226000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.412800E-01 |
| Normal-vs-Stage2 |
9.140000E-01 |
| Normal-vs-Stage3 |
3.585400E-01 |
| Normal-vs-Stage4 |
9.821400E-01 |
| Stage1-vs-Stage2 |
9.822400E-01 |
| Stage1-vs-Stage3 |
1.588770E-01 |
| Stage1-vs-Stage4 |
8.532200E-01 |
| Stage2-vs-Stage3 |
3.668800E-01 |
| Stage2-vs-Stage4 |
9.033400E-01 |
| Stage3-vs-Stage4 |
3.920600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.025800E-01 |
| Normal-vs-AfricanAmerican |
2.180200E-01 |
| Normal-vs-Asian |
9.187400E-01 |
| Caucasian-vs-AfricanAmerican |
2.867200E-01 |
| Caucasian-vs-Asian |
9.293600E-01 |
| AfricanAmerican-vs-Asian |
2.864000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.312800E-01 |
| Normal-vs-Female |
8.907600E-01 |
| Male-vs-Female |
3.275600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.626200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.122600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.151200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.101000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.278200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.229040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.596200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.597600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.601200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.591600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.423000E-01 |
| Classical-VS-Follicular |
1.61640001383745E-09 |
| Classical-VS-Other |
3.973700E-02 |
| Classical-VS-Normal |
1.757820E-01 |
| Tall-VS-Follicular |
1.543990E-02 |
| Tall-VS-Other |
1.507170E-01 |
| Tall-VS-Normal |
9.286600E-01 |
| Follicular-VS-Other |
9.802000E-01 |
| Follicular-VS-Normal |
1.176860E-03 |
| Other-VS-Normal |
1.027150E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.152200E-01 |
| Normal-vs-N1 |
1.353560E-01 |
| N0-vs-N1 |
3.072800E-01 |
|
|
